Cochlear Implant Systems

Hearing loss is a global healthcare problem that is highly prevalent and undertreated. More than 430 million people have disabling hearing loss requiring hearing rehabilitation, and this number is expected to grow to 700 million by 2050. Although more than 60 million people worldwide suffer from severe or higher hearing loss, cochlear implant market penetration is less than 5%, leaving significant room for growth.

Global sales of cochlear implant systems were estimated at nearly $1.5bn in 2022. Market drivers include steadily recovering cochlear implant sales (post COVID-19 pandemic shutdowns) and pent-up demand, increasing prevalence and unmet need, increasing awareness, expanding referrals, good reimbursement, expanding indications, and a strong clinical profile. Limiters include high cost, lack of awareness and access in developing regions, patient reluctance, and ongoing healthcare staffing shortages and elective surgery backlogs.

This analysis includes a discussion of products, current revenues and forecast markets, competitors, and opportunities in the global market for cochlear implant systems; revenues include sales of external and internal components (eg sound processors and internally implanted implants/electrode arrays), as well as sound processor upgrades, software apps, accessories, and services. Countries covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World. The forecast range for this report is 2022–27.

If you are not a subscriber to Meddevicetracker and would like to purchase this report, please send an email to [email protected]. If you would like more information about obtaining a subscription to the Meddevicetracker database and report library, please send an email to [email protected].